Globus Medical to Release Q4 Earnings and Host Conference Call
AUDUBON, Pa. — Globus Medical, Inc. (NYSE:GMED), a leader in musculoskeletal solutions, plans to share its financial results for the fourth quarter and full-year ended December 31, 2024, at market close on a Thursday in February 2025. The announcement will be followed by a teleconference to connect with the investment community where performance and future outlook will be discussed.
Details on the Earnings Announcement
The financial results will be disclosed on the official Globus Medical website, offering insights into the company’s ability to innovate and meet clinical needs within the musculoskeletal sector. Investors and interested parties can access the full earnings release at the company’s dedicated investor relations page, which provides additional updates about their operations and market strategies.
Investors Call and Teleconference Participation
Post-announcement, the teleconference will take place at 4:30 p.m. Eastern Time. For those wanting to join via the internet, access to the live webcast will be available on the Investors page of the Globus Medical website. This format allows investors to listen in on the discussion surrounding the latest developments directly from the company leaders.
How to Dial in to the Conference
Telephone participants are encouraged to register in advance to ensure a seamless experience. Confirmation emails will be sent to participants, detailing the ins and outs of the joining process, including dial-in numbers and unique passcodes for smooth access to the call. This structured approach helps maintain an organized and informative experience for all involved.
About Globus Medical, Inc.
Based in Audubon, Pennsylvania, Globus Medical, Inc. stands as a foremost global player within the musculoskeletal industry. The company is dedicated to advancing treatment methods through innovative technology, ensuring that clinical needs are met with urgency and efficacy. This commitment extends across various aspects of the field, including spine care, orthopedic trauma, joint reconstruction, and biomaterials, demonstrating the breadth of their capabilities and impact.
Focus on Innovation
Globus Medical’s innovative approaches significantly enhance medical practices and outcomes. With a core mission to change lives through cutting-edge technology, the company ensures that healthcare providers are equipped with the tools necessary to excel in patient care. Their involvement in rigorous education and training further contributes to the highest standards of clinical practice.
Investor and Media Contacts
The company maintains open lines of communication with investors and media representatives to foster beneficial relationships and ensure transparency. Key contacts include Brian Kearns, Senior Vice President of Corporate Development and Investor Relations, and Moran Chavez, Senior Director of Corporate Affairs. They are available for inquiries regarding investment information and media engagement.
Reaching Out
To facilitate efficient communication, inquiries can be submitted via direct contact information listed on the Globus Medical website. This commitment to accessibility underscores the company’s dedication to fostering strong relationships with stakeholders.
Frequently Asked Questions
What date is the earning release for Globus Medical?
The earnings release for Globus Medical is scheduled for a Thursday in February 2025.
How can I participate in the Globus Medical conference call?
Participants can join the conference call by registering in advance, after which they will receive a confirmation email with dialing details.
Where can I find the financial results?
The financial results will be available on the investor relations section of the Globus Medical website.
What is Globus Medical's focus area?
Globus Medical focuses on providing innovative solutions within the musculoskeletal field including spine care and orthopedic trauma.
Who can I contact for investor inquiries?
Brian Kearns, Senior Vice President of Corporate Development and Investor Relations, is the primary contact for investor inquiries.
